Production (Stage)
Evolutionary Genomics, Inc.
FNAM
$0.0002
-$0.0006-75.00%
OTC PK
| 12/31/2022 | 09/30/2022 | 06/30/2022 | 03/31/2022 | 12/31/2021 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | 66.94% | -84.16% | -22.03% | 2.38% | -170.11% |
| Gross Profit | -66.94% | 84.16% | 22.03% | -2.38% | 170.11% |
| SG&A Expenses | -22.70% | 7.54% | 1.87% | 2.13% | -12.58% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -38.30% | -52.23% | -4.03% | 2.14% | -64.18% |
| Operating Income | 38.30% | 52.23% | 4.03% | -2.14% | 64.18% |
| Income Before Tax | 50.01% | 48.49% | 4.08% | -2.18% | 60.97% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 50.01% | 48.49% | 4.08% | -2.18% | 60.97% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 50.01% | 48.49% | 4.08% | -2.18% | 60.97% |
| EBIT | 38.30% | 52.23% | 4.03% | -2.14% | 64.18% |
| EBITDA | 61.58% | 67.11% | 6.09% | -6.10% | 73.17% |
| EPS Basic | 50.44% | 51.02% | 13.26% | -1.61% | 58.53% |
| Normalized Basic EPS | 55.92% | 57.83% | 14.97% | -2.01% | 64.16% |
| EPS Diluted | 50.44% | 51.02% | 16.18% | -1.10% | 58.53% |
| Normalized Diluted EPS | 55.92% | 57.83% | 14.97% | -2.01% | 64.16% |
| Average Basic Shares Outstanding | 13.18% | 13.15% | 12.75% | 0.14% | 0.00% |
| Average Diluted Shares Outstanding | 13.18% | 13.15% | 12.75% | 0.14% | 0.00% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |